Abstract:Depression is a serious public health problem, and adolescence is an 'age of risk' for the onset of Major Depressive Disorder. Recently, we and others have proposed neuroimmune network models that highlight bidirectional communication between the brain and the immune system in both mental and physical health, including depression. These models draw on research indicating that the cellular actors (particularly monocytes) and signaling molecules (particularly cytokines) that orchestrate inflammation in the periphery can directly modulate the structure and function of the brain. In the brain, inflammatory activity heightens sensitivity to threats in the cortico-amygdala circuit, lowers sensitivity to rewards in the cortico-striatal circuit, and alters executive control and emotion regulation in the prefrontal cortex. When dysregulated, and particularly under conditions of chronic stress, inflammation can generate feelings of dysphoria, distress, and anhedonia. This is proposed to initiate unhealthy, self-medicating behaviors (e.g. substance use, poor diet) to manage the dysphoria, which further heighten inflammation. Over time, dysregulation in these brain circuits and the inflammatory response may compound each other to form a positive feedback loop, whereby dysregulation in one organ system exacerbates the other. We and others suggest that this neuroimmune dysregulation is a dynamic joint vulnerability for depression, particularly during adolescence. We have three goals for the present paper. First, we extend neuroimmune network models of mental and physical health to generate a developmental framework of risk for the onset of depression during adolescence. Second, we examine how a neuroimmune network perspective can help explain the high rates of comorbidity between depression and other psychiatric disorders across development, and multimorbidity between depression and stress-related medical illnesses. Finally, we consider how identifying neuroimmune pathways to depression can facilitate a 'next generation' of behavioral and biological interventions that target neuroimmune signaling to treat, and ideally prevent, depression in youth and adolescents.

The neurobiology of depression: An integrated view

Neurobiological Investigation of Depression: Unraveling the Biological Basis of a Complex Mental Health Challenge

The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression

New insights into the neurobiological mechanisms of major depressive disorders

The molecular neurobiology of depression

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Molecular pathways of major depressive disorder converge on the synapse

The neurobiology of depression—revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms

Pathogenesis of depression: Insights from human and rodent studies

Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?

Molecular Biological Aspects of Depressive Disorders: A Modern View

Prospective Role of MicroRNAs in Depression

Pathobiological targets of depression

Cognitive and Neural Aspects of Information Processing in Major Depressive Disorder: An Integrative Perspective

Neuroplasticity: Pathophysiology and Role in Major Depressive Disorder

The neurobiology of depression—revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies

Annual Research Review: Neuroimmune network model of depression: a developmental perspective

Analyzing the Genes and Pathways Related to Major Depressive Disorder Via a Systems Biology Approach

Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis

A comprehensive review of genetic and epigenetic mechanisms that regulate BDNF expression and function with relevance to major depressive disorder

Depression research: where are we now?